cjc 1295 ipamorelin mechanism of action gh igf 1 release CJC-1295 & Blend Dosing: Release, Ratio… HGH Frag 176-191 Ipamorelin CJC-1295

For orders under this amount, postage is just $7.90 NZD

The adaptation protocol Start low and increase gradually

It is expected that research in animal models using both peptides would indicate greater benefits without significantly raising side effects

CJC-1295 (without DAC) is a synthetic analog of GHRH(1-29) with four amino acid substitutions at positions 2, 8, 15, and 27 that confer resistance to DPP-IV and other plasma proteases

some are investigational drugs not approved by the FDA

Long arginine 3-IGF-1, abbreviated as IGF-1 LR3 or LR3-IGF-1, is a synthetic protein and lengthened analogue of human insulin-like growth factor 1 (IGF-1).[1][2] It differs from native IGF-1 in that it possesses an arginine instead of a glutamic acid at the third position in its amino acid sequence (arginine 3), and also has an additional 13 amino acids at its N-terminus (MFPAMPLLSLFVN) (long), for a total of 83 amino acids (relative to the 70 of IGF-1).[2] The consequences of these modifications are that IGF-1 LR3 retains the pharmacological activity of IGF-1 as an agonist of the IGF-1 receptor, has very low affinity for the insulin-like growth factor-binding proteins (IGFBPs), and has improved metabolic stability.[1][2] As a result, it is approximately three times more potent than IGF-1,[3] and possesses a significantly longer half-life of about 2030 hours (relative to IGF-1s half-life of about 1215 hours).[4] IGF-1 LR3 Peptide is under active investigation in a number of cell culture and animal models